Literature DB >> 4718495

Prophylactic oral antibiotics in the management of acute leukaemia.

J A Levi, P C Vincent, F Jennis, D E Lind, F W Gunz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4718495

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  7 in total

1.  [Clinical gnotobiotics in hematology].

Authors:  M Dietrich
Journal:  Blut       Date:  1974-05

2.  Infection in acute leukemia patients receiving oral nonabsorable antibiotics.

Authors:  D M Hahn; S C Schimpff; C L Fortner; A C Smyth; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

3.  E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods.

Authors: 
Journal:  Infection       Date:  1982       Impact factor: 3.553

4.  Recontamination after gastrointestinal decontamination with non-absorbable antibiotics.

Authors:  W D Hendriks; J de Vast; D van der Waaij
Journal:  Infection       Date:  1981       Impact factor: 3.553

5.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.

Authors:  J Dankert; W Gaus; H Gaya; D Krieger; G Linzenmeier; D van der Waaij
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patients.

Authors:  J F Bender; S C Schimpff; V M Young; C L Fortner; M D Brouillet; L J Love; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Concentrations of nystatin in faeces after oral administration of various doses of nystatin.

Authors:  W Hofstra; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1979       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.